Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exendin (9-39)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Early research (Phase 1)Study completedNCT01449019
What this trial is testing

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Ludwig-Maximilians - University of Munich 24
Post-approval studies (Phase 4)Study completedNCT02639130
What this trial is testing

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 67
Early research (Phase 1)Study completedNCT00551590
What this trial is testing

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ludwig-Maximilians - University of Munich 24
Testing effectiveness (Phase 2)Study completedNCT03373435
What this trial is testing

Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

Who this might be right for
Postbariatric Hypoglycemia
Eiger BioPharmaceuticals 18
Early research (Phase 1)Study completedNCT02996812
What this trial is testing

Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia

Who this might be right for
Hyperinsulinemia Hypoglycemia
Tracey McLaughlin 9
Early research (Phase 1)Study completedNCT00980083
What this trial is testing

GLP-1 - Regulatory Mechanism of Postprandial Glycemia

Who this might be right for
Healthy SubjectsGastric Emptying
Ludwig-Maximilians - University of Munich 12
Not applicableStudy completedNCT03246451
What this trial is testing

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

Who this might be right for
Glucose Metabolism Disorders
University Hospital, Gentofte, Copenhagen 15
Testing effectiveness (Phase 2)WithdrawnNCT02697253
What this trial is testing

Mechanisms Underlying Predictors of Success From Obesity Surgery

Who this might be right for
Obesity
Icahn School of Medicine at Mount Sinai
Early research (Phase 1)Study completedNCT00468091
What this trial is testing

Effects of Exendin(9-39) on Gastroduodenal Motility

Who this might be right for
Digestive PhysiologyGastrointestinal MotilityGastrointestinal Hormones+2 more
Ludwig-Maximilians - University of Munich 10
Early research (Phase 1)Study completedNCT00393445
What this trial is testing

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Who this might be right for
Hyperglycemia
Ludwig-Maximilians - University of Munich 6
Not applicableLooking for participantsNCT07373236
What this trial is testing

The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Asger Lund, MD 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06747468
What this trial is testing

Avexitide for Treatment of Post-Bariatric Hypoglycemia

Who this might be right for
Post Bariatric Hypoglycemia
Amylyx Pharmaceuticals Inc. 75
Testing effectiveness (Phase 2)Study completedNCT04652479
What this trial is testing

Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia

Who this might be right for
Acquired Hyperinsulinemic Hypoglycemia
Dr. Tracey McLaughlin, MD 25
Testing effectiveness (Phase 2)Ended earlyNCT00835328
What this trial is testing

Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia

Who this might be right for
Congenital Hyperinsulinism
Diva De Leon 14
Not applicableUnknownNCT01729299
What this trial is testing

Ghrelin Effect on Beta Cell Function in Health and Disease

Who this might be right for
Diabetes
David Dalessio 30
Not applicableStudy completedNCT03950245
What this trial is testing

Incretin Hormone Antagonism After Bariatric Surgery

Who this might be right for
Bariatric Surgery
Hvidovre University Hospital 36
Testing effectiveness (Phase 2)Study completedNCT02771574
What this trial is testing

Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

Who this might be right for
Post Bariatric Hypoglycemia
Tracey McLaughlin 19